Clinical Characteristics, Treatment Outcome and Associated Factors of Epilepsy Among Children at Hospitals of North-West Ethiopia.
Ethiopia
children
epilepsy
seizure
treatment outcome
Journal
Pediatric health, medicine and therapeutics
ISSN: 1179-9927
Titre abrégé: Pediatric Health Med Ther
Pays: New Zealand
ID NLM: 101655856
Informations de publication
Date de publication:
2023
2023
Historique:
received:
13
09
2023
accepted:
26
10
2023
medline:
6
11
2023
pubmed:
6
11
2023
entrez:
6
11
2023
Statut:
epublish
Résumé
Epilepsy is an important cause of neurological morbidity in children and adolescents. Clinical parameters are the main diagnostic tools, especially in developing countries. Although cost-effective treatments for epilepsy are available, studies have shown that uncontrolled seizures can occur in many patients. To assess clinical characteristics, treatment outcomes, and associated factors for controlled epilepsy among children with epilepsy who underwent follow-up at the Debre Markos Comprehensive Specialized Hospital, North-west Ethiopia from October 28, 2020, to April 28, 2021. An institutional-based retrospective cohort study was conducted from October 28, 2020, to April 28, 2021. A total of 385 participants who fulfilled the inclusion criteria were included in the study. A pretested, structured, interviewer-administered questionnaire with a chart review was used to collect data. The data were entered into the Epi-data software version 4.4.2.1 and then exported to the Stata version 14 statistical package for analysis. Descriptive statistics were used to describe the sociodemographic and clinical characteristics, treatment profiles, and treatment outcomes of patients with epilepsy. Bivariate and multivariate analyses were used to identify factors associated with treatment outcomes. The most frequent type of seizure among the 385 respondents was Generalized-tonic-clonic seizures (88.1%). The proximate cause of seizures was identified in 15% of patients, of whom 45 had a perinatal history (8.8%), head injury (3.6%), and CNS infection (2.3%). One-third of patients had poor seizure control. Caregiver relationship (father AOR=0.58; 95th CI:0.35,0.97) and poor adherence (AOR=2.97; 95th CI:1.82, 4.86) were significantly associated with treatment outcome. One-third of children with epilepsy have poor seizure control. Poor adherence to treatment is implicated in poor control. Counseling caregivers on proper treatment and adherence to anti-epileptic medication is recommended to improve treatment outcome in children.
Sections du résumé
Background
UNASSIGNED
Epilepsy is an important cause of neurological morbidity in children and adolescents. Clinical parameters are the main diagnostic tools, especially in developing countries. Although cost-effective treatments for epilepsy are available, studies have shown that uncontrolled seizures can occur in many patients.
Objective
UNASSIGNED
To assess clinical characteristics, treatment outcomes, and associated factors for controlled epilepsy among children with epilepsy who underwent follow-up at the Debre Markos Comprehensive Specialized Hospital, North-west Ethiopia from October 28, 2020, to April 28, 2021.
Methods
UNASSIGNED
An institutional-based retrospective cohort study was conducted from October 28, 2020, to April 28, 2021. A total of 385 participants who fulfilled the inclusion criteria were included in the study. A pretested, structured, interviewer-administered questionnaire with a chart review was used to collect data. The data were entered into the Epi-data software version 4.4.2.1 and then exported to the Stata version 14 statistical package for analysis. Descriptive statistics were used to describe the sociodemographic and clinical characteristics, treatment profiles, and treatment outcomes of patients with epilepsy. Bivariate and multivariate analyses were used to identify factors associated with treatment outcomes.
Results
UNASSIGNED
The most frequent type of seizure among the 385 respondents was Generalized-tonic-clonic seizures (88.1%). The proximate cause of seizures was identified in 15% of patients, of whom 45 had a perinatal history (8.8%), head injury (3.6%), and CNS infection (2.3%). One-third of patients had poor seizure control. Caregiver relationship (father AOR=0.58; 95th CI:0.35,0.97) and poor adherence (AOR=2.97; 95th CI:1.82, 4.86) were significantly associated with treatment outcome.
Conclusion
UNASSIGNED
One-third of children with epilepsy have poor seizure control. Poor adherence to treatment is implicated in poor control. Counseling caregivers on proper treatment and adherence to anti-epileptic medication is recommended to improve treatment outcome in children.
Identifiants
pubmed: 37927397
doi: 10.2147/PHMT.S436022
pii: 436022
pmc: PMC10625381
doi:
Types de publication
Journal Article
Langues
eng
Pagination
385-404Informations de copyright
© 2023 Nasir et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest regarding the publication of this article.
Références
Pharmacotherapy. 2000 Aug;20(8 Pt 2):191S-199S
pubmed: 10937819
JAMA Neurol. 2018 Mar 1;75(3):279-286
pubmed: 29279892
Epilepsia. 1997 Dec;38(12):1275-82
pubmed: 9578522
F1000Res. 2018 Dec 13;7:
pubmed: 30613377
Epilepsia. 2010 Jul;51(7):1189-97
pubmed: 20557350
Neurodiagn J. 2018;58(1):1-10
pubmed: 29562876
Epilepsy Behav. 2021 Apr;117:107816
pubmed: 33626491
Behav Neurol. 2016;2016:3189108
pubmed: 28053370
Pediatr Neurol. 1998 Jul;19(1):31-6
pubmed: 9682882
Neurol Clin. 2016 Nov;34(4):837-847
pubmed: 27719996
Epilepsy Behav. 2016 Oct;63:98-102
pubmed: 27588359
Epileptic Disord. 2013 Jun;15(2):101-4
pubmed: 23774399
BMC Neurol. 2022 Aug 23;22(1):310
pubmed: 35999500
PLoS One. 2020 Mar 12;15(3):e0230187
pubmed: 32163504
Epilepsy Res. 2020 Nov;167:106448
pubmed: 32916644
Lancet. 2006 Apr 1;367(9516):1087-1100
pubmed: 16581409
J Clin Neurol. 2016 Apr;12(2):160-5
pubmed: 26610892
Epilepsy Res. 2007 Jul;75(2-3):192-6
pubmed: 17628429
Cureus. 2020 Sep 20;12(9):e10549
pubmed: 33101797
Acta Paediatr Jpn. 1989 Jun;31(3):259-66
pubmed: 2508421
PLoS One. 2023 Jan 23;18(1):e0278936
pubmed: 36689466
Lancet. 2006 Feb 11;367(9509):499-524
pubmed: 16473127
Neurol Int. 2009 Nov 16;1(1):e20
pubmed: 21577358
BMC Neurol. 2013 Nov 21;13:182
pubmed: 24261551
Epilepsy Behav. 2019 Aug;97:44-50
pubmed: 31181428
Neurol Res Int. 2017;2017:4970691
pubmed: 29375913
Neurology. 2012 May 15;78(20):1548-54
pubmed: 22573629
Sci Rep. 2019 Nov 7;9(1):16254
pubmed: 31700030
Epilepsia. 1981 Feb;22(1):35-53
pubmed: 7472299
P R Health Sci J. 2020 Mar;39(1):45-50
pubmed: 32383567
Sci Rep. 2018 Nov 26;8(1):17354
pubmed: 30478263
Pediatr Neurol. 2009 Feb;40(2):71-7
pubmed: 19135617
Seizure. 2013 Nov;22(9):743-7
pubmed: 23806632
Epilepsia. 2017 Apr;58(4):512-521
pubmed: 28276062
Biomed Tech (Berl). 2020 Aug 27;65(4):379-391
pubmed: 31825886
Epilepsia. 2008 Aug;49 Suppl 6:13-8
pubmed: 18754956
J Child Neurol. 2015 Oct;30(12):1569-73
pubmed: 25808459
Neurol Res Int. 2020 Apr 08;2020:8109858
pubmed: 32328306
Epileptic Disord. 2018 Apr 1;20(2):77-87
pubmed: 29620013
Epilepsia Open. 2021 Feb 08;6(1):206-215
pubmed: 33681663
Med J Aust. 2018 Mar 19;208(5):226-233
pubmed: 29540143
Epilepsy Res Treat. 2012;2012:751510
pubmed: 22957241
Neuropsychiatr Dis Treat. 2016 Oct 12;12:2605-2616
pubmed: 27789949
Epilepsy Res. 2018 Dec;148:90-95
pubmed: 30396007
Lancet Neurol. 2014 Oct;13(10):1029-44
pubmed: 25231525
Epilepsia. 2014 Jan;55(1):76-85
pubmed: 24116877
Seizure. 2010 Nov;19(9):553-7
pubmed: 20739197
Epilepsia. 2008 Aug;49 Suppl 6:8-12
pubmed: 18754955
Neuropsychiatr Dis Treat. 2016 Dec 16;12:3213-3219
pubmed: 28053533
Epilepsy Behav. 2005 Feb;6(1):85-9
pubmed: 15652738
PLoS One. 2022 Feb 17;17(2):e0263821
pubmed: 35176045
Patient Relat Outcome Meas. 2020 Apr 21;11:119-127
pubmed: 32368167
Epilepsy Behav. 2019 Jul;96:92-97
pubmed: 31121513
Epilepsia Open. 2019 Feb 21;4(1):123-132
pubmed: 30868122
Seizure. 2012 May;21(4):266-72
pubmed: 22333178
Dev Med Child Neurol. 1990 Aug;32(8):661-8
pubmed: 2210081